Dr. Paauw is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
116 Nationwide Drive
Lynchburg, VA 24502Phone+1 434-947-3984Fax+1 434-947-5950
Education & Training
- Texas A&M College of Medicine-Scott and White Medical Center (Temple)Residency, Ophthalmology, 2005 - 2009
- University of Michigan Medical SchoolClass of 2005
Certifications & Licensure
- VA State Medical License 2015 - 2026
- MO State Medical License 2010 - 2016
- FL State Medical License 2009 - 2011
- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution Start of enrollment: 2023 Apr 20
Roles: Contact
Publications & Presentations
PubMed
- 46 citationsEfficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease: the ONSET-2 Phase 3, Randomized TrialDavid Wirta, Patrick Vollmer, James Paauw, Kuei-Hsun Chiu, Eugenia Henry
Ophthalmology. 2021-11-09 - 1 citationsLong-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study.Ehsan Sadri, James D Paauw, Joseph B Ciolino, Lisa Nijm, Blake Simmons
Cornea. 2024-11-01 - Incidence of Postsurgical Intraocular Inflammation 6 Months After Implantation with a Multifocal Intraocular Lens.James Paauw, Michael B Caplan, Mark Gallardo, Kristi Rushin, Jeffrey D Horn
Clinical Ophthalmology. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: